A new type of biocompatible draw solute, Na(+)-functionalized carbon quantum dots (Na_CQDs) with ultra-small size and rich ionic species, in forward osmosis (FO) is developed for seawater desalination. The aqueous dispersion of Na_CQDs demonstrates a high osmotic pressure, which allows high FO water flux and negligible reverse solute permeation.

Thermoresponsive magnetic nanoparticles (MNPs) as a class of smart materials that respond to a change in temperature may by used as a draw solute to extract water from brackish or seawater by forward osmosis (FO). A distinct advantage is the efficient regeneration of the draw solute and the recovery of water via heat-facilitated magnetic separation. However, the osmotic pressure attained by this type of draw solution is too low to counteract that of seawater. In this work, we have designed a FO draw solution based on multifunctional Fe3O4 nanoparticles grafted with copolymer poly(sodium styrene-4-sulfonate)-co-poly(N-isopropylacrylamide) (PSSS-PNIPAM). The resulting regenerable draw solution shows high osmotic pressure for seawater desalination. This is enabled by three essential functional components integrated within the nanostructure: (i) a Fe3O4 core that allows magnetic separation of the nanoparticles from the solvent, (ii) a thermoresponsive polymer, PNIPAM, that enables reversible clustering of the particles for further improved magnetic capturing at a temperature above its low critical solution temperature (LCST), and (iii) a polyelectrolyte, PSSS, that provides an osmotic pressure that is well above that of seawater.

No abstract

A dendrimer-based forward osmosis (FO) draw solute, poly­(amidoamine) terminated with sodium carboxylate groups (PAMAM-COONa), was investigated for seawater desalination. Compared with existing FO draw solutes, PAMAM-COONa offers unique advantages: (1) Its aqueous solution can generate high osmotic pressure because of the large number of −COONa groups. (2) The low viscosity of PAMAM-COONa solution can reduce internal concentration polarization (ICP), which adversely affects FO water flux. (3) PAMAM-COONa has a relatively large molecular size, favoring reduced reverse solute flux. In our FO tests using 2.5-generation (2.5G) PAMAM-COONa draw solution (33.3 wt %) and seawater (Singapore coast) feed solution, a relatively high water flux of 9 L m–2 h–1 was achieved with commercial HTI FO membrane. In addition, a considerably reduced reverse solute flux of PAMAM-COONa compared to that of NaCl was attained. After FO testing, the diluted PAMAM-COONa solution was reconcentrated to its original osmotic pressure with membrane distillation to produce desalinated water and to regenerate the draw solution. In addition to seawater desalination, the dendrimer-based FO draw solute may find applications in wastewater treatment and protein enrichment.

The present study aimed to investigate the protective effects of rhein on cerebral ischemic/reperfusion (I/R) injury in rats. The present study focused on the effect of rhein on oxidative stress and apoptotic factors, which are considered to serve an important role in the onset of I/R injury. Sprague-Dawley rats were subjected to middle cerebral artery occlusion. Neurological functional scores (NFSs) were evaluated according to the Zea Longa's score criteria and the area of brain infarct was determined by triphenyltetrazolium chloride staining. The morphology of the nerve cells in the cortex was observed following hematoxylin and eosin staining. In addition, levels of oxidative stress were assessed by measuring the levels of superoxide dismutase (SOD), glutathione-peroxidase (GSH-Px), catalase (CAT) and malondialdehyde (MDA). Levels of B-cell lymphoma-2 (Bcl-2), apoptosis regulator Bax (BAX), caspase-9, caspase-3 and cleaved caspase-3 expression were analyzed using western blot analysis. Levels of caspase-9 and caspase-3 mRNA expression were obtained using reverse transcription-quantitative polymerase chain reaction. The results revealed that treatment with 50 or 100 mg/kg rhein significantly improved the NFS and markedly attenuated the area of infarction. Rhein also significantly reduced the content of MDA and significantly increased SOD, GSH-Px and CAT activity. Western blot analysis indicated that rhein significantly decreased the expression of BAX and enhanced the expression of Bcl-2. Compared with the I/R group, levels of caspase-9, caspase-3 and cleaved caspase-3 protein expression were significantly decreased in the rhein treatment groups. Additionally, rhein treatment significantly reduced levels of caspase-9 and caspase-3 mRNA expression. These results suggest that rhein exhibits protective effects during cerebral I/R injury and its underlying mechanism of action may involve the inhibition of oxidative stress and apoptosis.